ONCBeOne Medicines AG
$377.78+19% 1Y
$377.78
$260.2752 weeks$386.38
Is the price fair?
What ONC's price assumes
BeOne Medicines AG has no trailing P/E on file, so the price is measured against sales instead: 77.9× revenue.
77.9
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 93.9
Price / book · as of 2026-Q1
- EV / sales
- 77.2
EV / sales
Details›
- Price / bookas of 2026-Q1
- 93.9
- EV / EBITas of 2026-Q1
- 646
- EV / salesas of 2026-Q1
- 77.2
- Market capitalisation113.7 million shares, counted Jul 31, 2026
- $43.0B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
The closest names by size in the same industry